Skip to content

Drug interactions

Eltrombopag + Nateglinide

Severity: Moderate

Eltrombopag and Nateglinide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Eltrombopag inhibits the OATP1B1 transporter, which helps nateglinide enter hepatocytes, so nateglinide exposure may rise. This can increase glucose lowering and the risk of hypoglycemia. The effect of nateglinide on eltrombopag is not clinically established.

What this interaction means in plain words

Eltrombopag and Nateglinide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Eltrombopag belongs to Miscellaneous; Nateglinide belongs to Endocrine.

Evidence level: Low

Why it happens

Eltrombopag inhibits OATP1B1, reducing hepatic uptake and clearance of nateglinide.

What to do

Monitor blood glucose when eltrombopag is started and lower the nateglinide dose if hypoglycemia develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eltrombopag and Nateglinide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Eltrombopag with Nateglinide?

MediHelp rates the interaction as moderate. Eltrombopag and Nateglinide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Eltrombopag inhibits the OATP1B1 transporter, which helps nateglinide enter hepatocytes, so nateglinide exposure may rise. This can increase glucose lowering and the risk of hypoglycemia. The effect of nateglinide on eltrombopag is not clinically established.

How serious is the interaction between Eltrombopag and Nateglinide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose when eltrombopag is started and lower the nateglinide dose if hypoglycemia develops.

What other medicines interact with Nateglinide?

MediHelp also lists interactions of Nateglinide with, for example, Albiglutide, Alogliptin-metformin, Alogliptin-pioglitazone. The full list is on the Nateglinide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in